Casdin Capital, LLC Diversified Active

CIK: 0001534261 · Show all filings

Period: Q4 2019 (← Previous) (Next →)

Filing Date: Feb 14, 2020

Total Value ($000): $1,087,417 (100.0% shares, 0.0% debt)

Holdings (32)

SRPT SAREPTA THERAPEUTICS INC 8.0%
Value ($000) $86,457 Shares 670,000 Est. Cost $121.78 Unrealized -17.1%
BLUEBIRD BIO INC 7.8%
Value ($000) $85,118 Shares 970,000 Est. Cost $24764.35 Unrealized
CDXS CODEXIS INC 7.5%
Value ($000) $81,130 Shares 5,073,780 Est. Cost $13.94 Unrealized +6.1%
BLUEPRINT MEDICINES CORP 6.9%
Value ($000) $75,303 Shares 940,000 Est. Cost $9221.69 Unrealized
MYOKARDIA INC 6.7%
Value ($000) $73,249 Shares 1,005,000 Est. Cost $39.07 Unrealized
ALNY ALNYLAM PHARMACEUTICALS INC 5.5%
Value ($000) $59,313 Shares 515,000 Est. Cost $81.37 Unrealized +22.5%
INVITAE CORP 5.4%
Value ($000) $58,687 Shares 3,638,388 Est. Cost $10040.39 Unrealized
CONSTELLATION PHARMCETICLS I 5.3%
Value ($000) $57,132 Shares 1,212,734 Est. Cost $6.31 Unrealized
AUDENTES THERAPEUTICS INC 4.7%
Value ($000) $51,462 Shares 860,000 Est. Cost $26.14 Unrealized
FATE FATE THERAPEUTICS INC 4.6%
Value ($000) $49,904 Shares 2,550,000 Est. Cost $4.33 Unrealized +266.9%
MAGENTA THERAPEUTICS INC 4.3%
Value ($000) $46,968 Shares 3,098,121 Est. Cost $1872.70 Unrealized
BLFS BIOLIFE SOLUTIONS INC 3.7%
Value ($000) $39,941 Shares 2,468,571 Est. Cost $15.40 Unrealized +5.6%
AGIO AGIOS PHARMACEUTICALS INC 3.6%
Value ($000) $39,394 Shares 825,000 Est. Cost $52.35 Unrealized -27.8%
CDNA CAREDX INC 2.4%
Value ($000) $25,884 Shares 1,200,000 Est. Cost $24.20 Unrealized -5.2%
GLOBAL BLOOD THERAPEUTICS IN 2.2%
Value ($000) $23,847 Shares 300,000 Est. Cost $32.45 Unrealized
DNLI DENALI THERAPEUTICS INC 2.0%
Value ($000) $21,775 Shares 1,250,000 Est. Cost $18.64 Unrealized -10.7%
FULC FULCRUM THERAPEUTICS INC 1.9%
Value ($000) $20,622 Shares 1,239,285 Est. Cost $10.58 Unrealized -9.7%
ILMN ILLUMINA INC 1.8%
Value ($000) $19,904 Shares 60,000 Est. Cost $196.93 Unrealized +53.9%
GRITSTONE ONCOLOGY INC 1.8%
Value ($000) $19,375 Shares 2,160,000 Est. Cost $3358.13 Unrealized
ALEC ALECTOR INC 1.7%
Value ($000) $18,540 Shares 1,076,039 Est. Cost $18.52 Unrealized -8.2%
SAGE THERAPEUTICS INC 1.5%
Value ($000) $16,604 Shares 230,000 Est. Cost $89.71 Unrealized
GENMARK DIAGNOSTICS INC 1.5%
Value ($000) $16,186 Shares 3,365,000 Est. Cost $6.69 Unrealized
DECIPHERA PHARMACEUTICALS IN 1.5%
Value ($000) $15,871 Shares 255,000 Est. Cost $13347.64 Unrealized
VYGR VOYAGER THERAPEUTICS INC 1.4%
Value ($000) $15,276 Shares 1,095,075 Est. Cost $14.86 Unrealized
ADPT ADAPTIVE BIOTECHNOLOGIES COR 1.3%
Value ($000) $13,857 Shares 463,125 Est. Cost $44.30 Unrealized -35.2%
GILD GILEAD SCIENCES INC 1.2%
Value ($000) $12,996 Shares 200,000 Est. Cost Unrealized
SGMO SANGAMO THERAPEUTICS INC 1.1%
Value ($000) $12,178 Shares 1,455,000 Est. Cost $8.80 Unrealized +4.5%
ORCHARD THERAPEUTICS PLC 1.0%
Value ($000) $11,275 Shares 820,000 Est. Cost $4757.09 Unrealized
TWST TWIST BIOSCIENCE CORP 0.6%
Value ($000) $6,300 Shares 300,000 Est. Cost $26.45 Unrealized -11.5%
TURNING POINT THERAPEUTICS I 0.4%
Value ($000) $4,672 Shares 75,000 Est. Cost $40080.00 Unrealized
BRISTOL MYERS SQUIBB CO 0.4%
Value ($000) $4,515 Shares 1,500,000 Est. Cost $3.01 Unrealized
STOK STOKE THERAPEUTICS INC 0.3%
Value ($000) $3,682 Shares 130,000 Est. Cost $27.21 Unrealized -7.6%